Skip to main content
Premium Trial:

Request an Annual Quote

Canadian Bioinformatics Firm Raises $4.5 Million From Private Investors


MISSISSAUGA, Ont.--Last month Base4 Bioinformatics, a subsidiary here of Allelix Biopharmaceuti cals, announced that it has closed a private placement financing for $4.5 million. Investors include BioCapital Investments, Tera Capital, and Working Ventures Canadian Fund. The funding means that while Allelix remains a major shareholder in Base4, its share of the company has dropped to under 50 percent.

The new money will be used to extend Base4's library of bioinformatics software solutions, open more branch offices to improve customer service, and accelerate business development, according to Martin Sumner-Smith, Base4's president. Graham Stachan, Allelix's president and CEO, called the financing "a major step forward."

Filed under

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.